BIT Capital GmbH Purchases 323,365 Shares of Omada Health, Inc. $OMDA

BIT Capital GmbH raised its position in Omada Health, Inc. (NASDAQ:OMDA) by 52.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 940,238 shares of the company’s stock after purchasing an additional 323,365 shares during the period. BIT Capital GmbH’s holdings in Omada Health were worth $14,837,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of OMDA. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Omada Health in the 4th quarter valued at about $1,222,000. Divisadero Street Capital Management LP purchased a new stake in Omada Health in the 3rd quarter valued at about $30,510,000. a16z Perennial Management L.P. acquired a new position in Omada Health in the 4th quarter valued at about $2,480,000. Madryn Asset Management LP acquired a new position in Omada Health in the 4th quarter valued at about $9,212,000. Finally, Tudor Investment Corp ET AL acquired a new position in Omada Health in the 3rd quarter valued at about $987,000.

Omada Health Stock Performance

Shares of Omada Health stock opened at $17.93 on Friday. Omada Health, Inc. has a one year low of $10.28 and a one year high of $28.40. The company has a market cap of $1.07 billion and a PE ratio of -66.41. The business has a 50-day simple moving average of $14.83 and a 200-day simple moving average of $14.88.

Omada Health (NASDAQ:OMDA) last announced its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The business had revenue of $78.05 million during the quarter. On average, sell-side analysts predict that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms have weighed in on OMDA. Needham & Company LLC reaffirmed a “buy” rating and issued a $28.00 target price on shares of Omada Health in a research report on Friday, May 8th. Citigroup reaffirmed an “outperform” rating on shares of Omada Health in a research report on Friday, May 8th. Wells Fargo & Company lifted their target price on Omada Health from $17.00 to $18.00 and gave the company an “equal weight” rating in a research report on Friday, May 8th. Barclays lifted their target price on Omada Health from $18.00 to $20.00 and gave the company an “overweight” rating in a research report on Friday, May 8th. Finally, Citizens Jmp boosted their price objective on Omada Health from $18.00 to $21.00 and gave the stock a “market outperform” rating in a research report on Friday, May 8th. Ten equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Omada Health presently has a consensus rating of “Moderate Buy” and an average target price of $22.91.

Insider Transactions at Omada Health

In related news, President Wei-Li Shao sold 2,829 shares of the business’s stock in a transaction that occurred on Wednesday, April 8th. The stock was sold at an average price of $12.71, for a total transaction of $35,956.59. Following the completion of the sale, the president owned 328,850 shares in the company, valued at $4,179,683.50. The trade was a 0.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sean P. Duffy sold 4,063 shares of the company’s stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $14.34, for a total value of $58,263.42. Following the completion of the transaction, the chief executive officer directly owned 117,598 shares of the company’s stock, valued at $1,686,355.32. This trade represents a 3.34% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 8,776 shares of company stock valued at $120,483. 6.38% of the stock is currently owned by corporate insiders.

Omada Health Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.